China YCT International Group, Inc. Announces Financial Results for Fourth Quarter and Fiscal Year 2009

* Reuters is not responsible for the content in this press release.

Tue Jun 30, 2009 8:30am EDT

  SHANDONG, CHINA, Jun 30 (MARKET WIRE) -- 
China YCT International Group, Inc., (OTCBB: CYIG) ("China YCT" or "the
Company"), a leading company engaged in the business of developing,
manufacturing and marketing gingko-based products through its wholly
owned subsidiary, Shandong Spring Pharmaceutical Co. Ltd, today announced
its audited financial results for the fourth quarter and full fiscal year
2009 ended March 31, 2009.

    Fourth Quarter Fiscal Year 2009 Results

    For the fourth quarter of fiscal year 2009, net sales totaled $3.84
million, a decrease of 35.4% compared to $5.95 million recorded in the
fourth quarter of fiscal year 2008.

    Gross profit totaled $2.10 million, a decrease of 36.9% compared to $3.33
million in the fourth quarter of fiscal year 2008.

    Net income for the fourth quarter was $1.02 million, or diluted income per
share of $0.03, compared to net income of $1.6 million, or diluted income
per share of $0.05 in the fourth quarter of fiscal year 2008.

    "During the fourth quarter of fiscal year 2009, we felt the effects of the
global economic slowdown," stated Mr. Yan Tinghe, the Company's Chairman.
"In addition, with an earlier than normal start to the Chinese New Year
this year, there was an extended period of minimized business activity for
our dealers."

    Fiscal Year 2009 Results

    For the fiscal year 2009, net sales totaled $25.8 million, an increase of
55.6%, compared to $16.5 million in fiscal year 2008.

    Gross profit totaled $14.4 million in fiscal year 2009, an increase of
55.8%, compared to $9.24 million in fiscal year 2008.

    Selling, general and administrative expenses were equal to 16.1% of our
net sales as compared to 21.6% in the year ended March 31, 2008. This
difference is due to the fact that during the fiscal year ended March 31,
2008, our selling, general and administrative expenses included a one time
charge of $683,987 related to our going public expenses.

    Excluding this one time expense, our selling, general and administrative
expenses as a percent of net sales for the fiscal year ended March 31,
2008 would have been 18.3%. We have been able to lower our selling,
general and administrative expenses as a percentage of net sales year on
year as a result of our management's ability to lower costs while
maximizing the efficiencies of our business.

    Net income totaled $7.4 million, or diluted EPS of $0.25, compared to $3.8
million in fiscal year 2008, or diluted EPS of $0.13.

    As of March 31, 2009, the Company's total cash and cash equivalents were
$10.0 million compared to $1.6 million at March 31, 2008. Net working
capital was $11.0 million as of March 31, 2009, compared to $5.1 million
at March 31, 2008.

    Total shareholders' equity increased to $16.7 million as of March 31, 2009
from $9.0 million at March 31, 2008.

    The total shares outstanding on a fully diluted basis as of March 31, 2009
were 29.3 million.

    "In spite of the global weakening of consumer spending, we were able to
achieve an increase in net sales in fiscal year 2009," added Mr. Yan
Tinghe. "However, I believe in the short term, demand for our current
product line will remain relatively unchanged. With that being said, given
our strong cash position, we are currently aggressively pursuing
opportunities to expand the current product line so we can offer new
products to our loyal base of dealers and end user customers."

    About China YCT International Group, Inc.

    Established in 2005, China YCT International Group, Inc., through its
operating subsidiary, Shandong Spring Pharmaceutical Co. Ltd. ("Shandong
Spring Pharmaceutical"), a corporation organized under the laws of the
People's Republic of China, is a high-tech enterprise, which applies
modern biological technology and integrates research & development,
production and sales of ginkgo healthcare products, ginkgo cosmetics,
daily-use chemical products, ginkgo glycoside products and biological
medicines. All of Shandong YCT's businesses are currently in China.

    Safe Harbor Statement

    The statements contained herein that are not historical facts are
"forward-looking statements" within the meaning of Section 21E of the
Securities and Exchange Act of 1934, as amended, and the Private
Securities Litigation Reform Act of 1995. Such forward-looking statements
may be identified by, among other things, the use of forward-looking
terminology such as "believes," "expects," "may," "will," "should," or
"anticipates" or the negative thereof or other variations thereon or
comparable terminology, or by discussions of strategy that involve risks
and uncertainties. In particular, our statements regarding the potential
growth of the markets are examples of such forward-looking statements.
The forward-looking statements include risks and uncertainties, including
but not limited to, general economic conditions and regulatory
developments, not within our control. The factors discussed herein and
expressed from time to time in our filings with the Securities and
Exchange Commission could cause actual results and developments to be
materially different from those expressed or implied by such statements.
The forward-looking statements are made only as of the date of this
filing, and we undertake no obligation to publicly update such
forward-looking statements to reflect subsequent events or
circumstances.



                    CHINA YCT INTERNATIONAL GROUP, INC.
                        CONSOLIDATED BALANCE SHEETS

                             ASSETS
                                                           March 31,
                                                      2009         2008
                                                  ------------ ------------
Current assets:
  Cash and cash equivalents                       $ 10,048,380 $  1,614,336
  Inventory                                              8,346      737,153
  Advance to suppliers                                       -      834,284
  Other receivable - related party                   2,075,549    2,022,742
                                                  ------------ ------------
      Total Current Assets                          12,132,275    5,208,515

Property and equipment, net of accumulated
 depreciation of $133,670 and $68,282,
 respectively                                        4,349,493    3,083,031

Land use right, net of accumulated amortization      1,411,274    1,404,803
                                                  ------------ ------------

    Total Assets                                  $ 17,893,042 $  9,696,349
                                                  ============ ============

              LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
  Accounts payable                                $    456,568 $     59,688
  Unearned Revenue                                           -       33,742
  Taxes payable                                        485,438      563,135
  Accrued expenses and other payables                  189,890       32,994
                                                  ------------ ------------
      Total Current Liabilities                      1,131,896      689,559
                                                  ------------ ------------

Stockholders' Equity
  Preferred stock series A, $500 par value, 45
   shares authorized and outstanding as of
   March 31, 2009 and 2008 respectively                 22,500       22,500
  Preferred stock series B convertible, $0.001
   par value, 5,000,000 shares authorized,
   -0- shares issued and outstanding                         -            -
  Common stock, $0.001 par value, 100,000,000
   shares authorized; 29,380,073 shares issued
   and outstanding as of  March 31, 2009 and
   2008, respectively                                   29,380       29,380
  Additional paid-in capital                         4,063,039    4,063,039
  Accumulated other comprehensive income             1,130,576      857,763
  Retained earnings                                 11,515,651    4,034,108
                                                  ------------ ------------
      Total Stockholders' Equity                    16,761,146    9,006,790
                                                  ------------ ------------

    Total Liabilities and Stockholders' Equity    $ 17,893,042 $  9,696,349
                                                  ============ ============

                    CHINA YCT INTERNATIONAL GROUP, INC.
                    CONSOLIDATED STATEMENTS OF INCOME
                      FOR THE YEARS ENDED MARCH 31,

                                                    2009          2008
                                                ------------  ------------

Revenues                                        $ 25,817,447  $ 16,586,741

Cost of Goods Sold                                11,323,587     7,322,143
                                                ------------  ------------

Gross Profit                                      14,493,860     9,264,598

Operating Expenses
   Research and development expenses                 181,531       141,241
   Selling, general and administrative             4,167,322     3,586,140
                                                ------------  ------------

Income Before Other Expenses                      10,145,007     5,537,217

Other Expenses                                       (83,799)     (116,255)
                                                ------------  ------------

Income Before Income Taxes                        10,061,209     5,420,962

Provision for Income Taxes                         2,579,666     1,534,620
                                                ------------  ------------

Net Income                                      $  7,481,543  $  3,886,342

Other Comprehensive Income:
   Foreign currency translation adjustment           272,813       696,468
                                                ------------  ------------

Comprehensive Income                            $  7,754,356  $  4,582,810
                                                ============  ============

Basic and diluted income per common share
   Basic and Diluted                            $       0.25  $       0.13
                                                ============  ============

Weighted average number of common shares
 outstanding
   Basic and Diluted                              29,380,073    29,300,825
                                                ============  ============

                    CHINA YCT INTERNATIONAL GROUP, INC.
                  CONSOLIDATED STATEMENTS OF CASH FLOWS
                      FOR THE YEARS ENDED MARCH 31,

                                                 2009            2008
                                            --------------  --------------
Cash Flows From Operating Activities:
   Net income                               $    7,481,543  $    3,886,342
   Adjustments to reconcile net income to
    net cash provided by operating
    activities:
      Depreciation and amortization                180,332          72,115

   Changes in operating assets and
    liabilities:
      Inventory                                    728,807        (737,153)
      Advance to suppliers                         834,284        (834,284)
      Other receivable - related party             (52,806)     (1,504,116)
      Accounts payable                             396,880         (19,740)
      Unearned revenue                             (33,742)         33,742
      Taxes payable                                (77,697)        563,135
      Accrued expenses and other payables          156,894        (104,035)
                                            --------------  --------------

         Cash provided by operating
          activities                             9,614,495       1,356,006
                                            --------------  --------------

Cash Flows From Investing Activities:
      Addition to plant and equipment           (1,330,350)       (418,745)
      Purchase of land use right                         -        (308,298)
                                            --------------  --------------

         Cash used in investing activities      (1,330,350)       (727,043)
                                            --------------  --------------

Cash Flows From Financing Activities
         Cash provided by financing
          activities                                     -               -
                                            --------------  --------------

Effect of exchange rate changes on cash and
 cash equivalents                                  149,899         305,602
                                            --------------  --------------

Increase in cash and cash equivalents            8,434,044         934,566

Cash and Cash Equivalents - Beginning of
 years                                           1,614,336         679,770
                                            --------------  --------------

Cash and Cash Equivalents - Ending of years $   10,048,380  $    1,614,336
                                            ==============  ==============

Supplemental disclosures of cash flow
 information:

      Interest paid                         $            -  $            -
                                            ==============  ==============
      Income Taxes paid                     $    2,608,665  $    1,196,189
                                            ==============  ==============


    




Copyright 2009, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.